Table 2.
Immunization and vitamin A supplementation visit attendance.
| Facility visit | Intervention No. (%) | Control No. (%) | aOR (95% CI) | P value |
|---|---|---|---|---|
| Pentavalent 1a (6 wk) | 691 (86.6) | 607 (76.1) | 2.85 (1.85-4.37) | <0.001 |
| Pentavalent 2a (10 wk) | 646 (81.0) | 537 (67.3) | 2.80 (1.88-4.17) | <0.001 |
| Pentavalent 3a (14 wk) | 592 (74.2) | 465 (58.3) | 2.68 (1.84-3.91) | <0.001 |
| Vitamin A (6 mo) | 516 (64.7) | 325 (40.7) | 5.67 (3.48-9.23) | <0.001 |
| MMRb/yellow fever (9 mo) | 484 (60.7) | 302 (37.8) | 4.52 (2.84-7.20) | <0.001 |
CI: confidence interval; aOR: adjusted odds ratio; N=1596 mother-child pairs. Models adjusted for: mother’s age, language, occupation, education; child age and gender; facility location (rural, semi-urban, town), type and number of messages provided.
aDiphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type B.
bMeasles, mumps, rubella.